Natick
Massachusetts
MetaStat
is a molecular diagnostic company that develops and commercializes diagnostic tests for the prediction of breast, lung and prostate cancers... Read moreMetaStat
is a molecular diagnostic company that develops and commercializes diagnostic tests for the prediction of breast, lung and prostate cancers... Read moreNews
Nov 21, 2018
BioPortfolio
MetaStat: MetaStat Inc MTST Medical Equipment Deals and Alliances Profile Report Updated 23102018 Prices from USD $250
Aug 31, 2018
BioPortfolio
MetaStat: metastat inc mtst medical equipment deals and alliances profile Report Updated 12072018 Prices from USD $250
Jul 17, 2018
BioPortfolio
MetaStat: MetaStat Voluntarily Withdraws Listing on the OTCQB and Files Form 15 to Suspend its Reporting Obligations
Jun 21, 2018
BioPortfolio
MetaStat: MetaStat Presents Positive Data Showing Inhibition of the MENApathway Reduces Cancer Cell Dissemination and Paclitaxel Resistance in Aggressive Cancer
Apr 06, 2018
Market Exclusive
MetaStat: MetaStat, Inc. (OTCMKTS:MTST) Files An 8-K Entry into a Material Definitive Agreement
Apr 03, 2018
BioPortfolio
MetaStat: MetaStat Inc MTST Financial and Strategic SWOT Analysis Review Report Updated 09032018 Prices from USD $300
Mar 30, 2018
sec
MetaStat: Received $3.4M in Debt Funding
Feb 28, 2018
BioPortfolio
MetaStat: MetaStat Announces Positive Topline Data Showing Over 50 Reduction in Cancer Metastasis from Preclinical Studies Evaluating Inhibition of the MAPKAPK2 Kinase Pathway
Nov 17, 2017
BioPortfolio
MetaStat: MetaStat Inc MTST Financial and Strategic SWOT Analysis Review Report Updated 13112017 Prices from USD $300
Nov 03, 2017
Market Exclusive
MetaStat: MetaStat, Inc. (OTCMKTS:MTST) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers